A serological assay to detect SARS-CoV-2 seroconversion in humans
Icahn School of Medicine at Mount Sinai · BOKU University · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,965
total citations
- FWCI
- 45.94
- Percentile
- 100%
- References
- 36
Citations per year
Authors
30- FAFatima AmanatCorresponding
Icahn School of Medicine at Mount Sinai
- DSDaniel Stadlbauer
Icahn School of Medicine at Mount Sinai
- SSShirin Strohmeier
BOKU University, Icahn School of Medicine at Mount Sinai
- THThi H. O. Nguyen
The University of Melbourne, Peter Doherty Institute
- VCVeronika Chromikova
Icahn School of Medicine at Mount Sinai
Topics & keywords
Topics
Keywords
- Serology
- Seroconversion
- Virology
- Antibody
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Immunology
- Coronavirus disease 2019 (COVID-19)
- Medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- MSMount Sinai Health System
- TBTexas Biomedical Research Institute
- OPOpen Philanthropy ProjectAwards: 75N93019C00051, HHSN272201400008C
- AOAcademy of FinlandAward: TYH2018322
- FUFudan University
- JJJane ja Aatos Erkon Säätiö
- NINational Institutes of HealthAwards: U54TR001433, 75N93019C00051, COVID-19, USA-WA1/2020, HHSN272201400008C
- CFCenters for Disease Control and Prevention
- MRMedical Research CouncilAward: COVID-19
- NHNational Health and Medical Research CouncilAwards: 1071916, 1102792
- NINational Institute of Allergy and Infectious DiseasesAwards: COVID-19, HHSN272201400008C, 75N93019C00051